PTO Won't Let Lipitor Patent Last Past 2010

Law360, New York (August 17, 2007, 12:00 AM EDT) -- The U.S. Patent and Trademark Office dealt Pfizer Inc. another blow Thursday in the company's ongoing fight to hang onto its patents to the world's best-selling drug, cholesterol treatment Lipitor, when it rejected the drugmaker's bid to extend one of the patents.

However, it did give the pharmaceutical giant a glimmer of hope in its classification of the decision as non-final, meaning the company could appeal.

Pfizer had asked the agency to reissue one of the patents so that it could retain market exclusivity for the...
To view the full article, register now.